Global Burden of Disease Health Financing Collaborator Network
1
Global Health Alliance-Deutschland (GHA-D)
1
Global Heart Journal
1
Global Mental Health
1
Global Research on Developmental Disabilities Collaborators
1
Gojka Roglic, Cherian Varghese, Leanne Riley et al.
1
Governement of Nepal, Ministry of Health
1
Government of the People's Republic of Bangladesh DGHS Directorate General of Health Services Ministry of Health and Family Welfare
1
Gómez-Ochoa, S., Rojas, L., Echeverría, L.,
1
Greenstone, M.
1
Gribble RSF, Liese BH, Wickremsinhe MN
1
Guo Y., , Ye T., et al.
1
H. E. Erskine
1
H. Ritchie
1
H. Ritchie and M. Roser
1
H. Sakamoto
1
Hagan, J.
1
Hanlon et al.
1
Heart, BMJ journals
1
HelpAge International Myanmar, University of Public Health and University of Medicine-2
1
HIV Economics Reference Group
1
Hommes F, Stratil J, Ströbele L, Bruchhausen W
1
Horton, Susan, et al.
1
Humanitarian Practice Network at ODI
1
IHME Institut for Health Metrics and Evaluation
1
ILEP International Federation of Anti-Leprosy Associations
1
Imperial College COVID-19 Response Team
1
India State-Level Disease Burden Initiative CRD Collaborators
1
India State-Level Disease Burden Initiative CVD Collaborators
1
India State-Level Disease Burden Initiative Diabetes Collaborators
1
India State-Level Disease Burden Initiative Neurological Disorders Collaborators
1
India State-Level Disease Burden Initiative Suicide Collaborators
1
Institute for Health Metrics and Evaluation (IHME), The Lancet
1
Institute of Health Metrics and Evaluation
1
International Bank for Reconstruction and Development
1
International Bank for Reconstruction and Development/ The World Bank
1
International Labour Organization (ILO)
1
International Union of Forest Research Organizations (IUFRO)
1
J. Dieleman, L. Singh et al.
1
J. E Wright, N. Aksee, et al.
1
J. G. Scott
1
Jack, H.
1
Jamie Bartram, Sandy Cairncross, Thomas Clasen et al.
1
Jamison, Dean T.
1
Jannsen
1
Jornal of Global Health Science
1
Kamali, M.
1
Karolin Seitz
1
Kelsey Vaughan & Aradhana Thapa
1
Kementerian Kesehatan RI
1
Khan, J.
1
Kobusingye, Olive
1
Kohler, S.
1
Kohn R, Ali A, Puac-Polanco V, Figueroa C, López-Soto V, Morgan K, et al.
1
Kola, L.
1
L.E. Escobar, R. Lowe et al.
1
Lancet
1
Lawrence, E.
1
Li Z., Richter L., Lu C.
1
Liu Xiaoyun
1
Lu C., Li Z.
1
M. J. Stirratt
1
M. K. Sugai et al.
1
M. L. Baranne
1
M. Manova
1
M. Roser
1
Mailloux, N.A. et al.
1
McGloin, J.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Ministerio de Salud - Chile
1
Ministerio de Salud - Peru
1
Ministry of Health & Family Welfare, India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Social Services Namibia
1
Ministry Of Health Community, Development,Gender, Elderly And Children, the United Republic of Tanzania
1
Ministry of Health Ghana
1
Ministry of Health, Rwanda
1
Ministry of Health, Zambia
1
Misereor, Brot für die Welt, GPF
1
Mock C. N., Nugent R. et. al.
1
Mock, Charles N.
1
Moraes de Oliveira, G et al
1
Mujaddid
1
Murray, C.A.
1
Mursaleena Islam
1
N. Nguyen
1
N.Paul, T. Bärnighausen, P. Geldsetzer
1
National AIDS Control Organisation (NACO), Ministry of Health & Family Welfare, Government of India
1
Nature Communications
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nepal Public Health Foundation
1
Nilar Tin et al.
1
Nomura, S.
1
Nugent, Rachel
1
O. Aderomilehin
1
O. Gureje & A. Alem
1
O. O. Ozoya
1
OECD Publishing, Paris
1
Ojji, D.B.
1
Olivia Tiberi
1
Organisation de la Santé Mondiale
1
Organisation for Economic Co-operation and Development (OECD), Eurostat and World Health Organization (WHO)
1
Organisation Mondiale de la Santé OMS
1
Organización Panamericana de la Salud
1
OVID-19 Excess Mortality Collaborators
1
Oxfam
1
P. Booth
1
P. Glaziou, C.Sismanidis, P. J. Dodd, et al.
1
P. Zitko, Á. Passi-Solar et al.
1
Paolella, D .A.
1
Patel V.
1
Phone Myint
1
PLOS Medecine
1
PLOS Medicine
1
PLoS Neglected Tropical diseases
1
Preussler, S.
1
Promotion Santé Suisse
1
Pubmed
1
R. H. Remien
1
R. Thompson, G. Fontana, et al.
1
R.d M. Rapee
1
R.G. Wagner, I. Petersen, et al.
1
Rebecca Holmes
1
Rev Panam Salud Publica
1
S. Tanna
1
Sao Paulo Medical Journal
1
Saxena, S.
1
Stevens, Gretchen
1
STRIVE
1
Stroke Alliance for Europe, King's College London
1
T. Lievens
1
Tang, Shenglan
1
Tanzania Ministry of Health, Community Development, Gender, Elderly and Children.
1
Tefera, S.
1
Teferi, M.
1
Tessum, C.
1
Than Tun Sein
1
The Economist Intelligence Unit Limited
1
The Global Fund
1
The Journal of Global Health
1
The Journal of Headache and Pain
1
The Republic of the Union of Myanmar, Ministry of Health and Sports
1
The Republic of the Union of Myanmar, Ministry of Health and Sports, Department of Health
1
Therapeutic advances in infectious disease
1
UN Children's Fund UNICEF
1
UN Environment
1
UN Mission for Ebola Emergency Response
1
UNDP
1
UNHCR
1
United Nations Children’s Fund (UNICEF)
1
United Nations Office on Drug and Crime UNODOC
1
University of Chicago’s Energy Policy Institute
1
University of Sheffield
1
Ursula M Read, Edward Adiibokah and Solomon Nyame
1
USAID, Health Systems 20
1
V. Huber, C. F.Sheng Ng et al.
1
Vikram Patel, Dan Chisholm, Tarun Dua et al.
1
Wagner, R.C.
1
Wagner, U. et al.
1
Wamai, R.
1
Welburn S. C., Beange I. et al
1
WHO, Department of Reproductive Health and Research, London School of Hygiene and Tropical Medicine, South African Medical Research Council
1
WHO, Regional Office Africa
1
WHO, UNFPA, and Escuela Andaluza de Salud Publica Consejeria de Salud
1
Wolters Kluwer
1
Word Health Organization
1
World Bank Group
1
World Health Organisation
1
World Health Organization (Bangladesh)
1
World Health Organization (WHO), Regional Office for South-East-Asia
1
World Health Organization WHO, et al.
1
World Health Organization WHO, International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
1
World Health Organization, Pan American Health Organization
1
World Health Organization, Regional Office for South-East Asia
1
World Health Organization, WFN
1
Zhao,Q.
1
Zhu, Anna
1
Ziaggi, G.
1
ВОЗ
1
Всемирная Организация Здравоохранения
1
Publication Years
2020-2024
129
2010-2019
140
2000-2009
5
Category
Studies & Reports
32
Policies
26
Statistics
13
Guidelines
9
COVID-19
5
Vaccine-preventable Diseases
5
Countries
5
Women & Child Health
4
Mental Health
4
Age & Elderly
4
Disease Prevention & Control
4
Vector Control
3
Sexual Violence
3
Community Health
3
Capacity Building
3
Child Health
2
Lymphaticfilariasis
2
Monitoring & Evaluation
2
Health System Strengthening
2
Chagas
2
NCD
2
Clinical Guidelines
2
Disabilities
2
Other
2
Surgery & Anaesthesia
2
Primary Health Care
2
Non-communicable Diseases
2
Reproductive Health
2
Dental & Eye Care
1
Hepatitis
1
Sanitation
1
Gender
1
Neurology & Psychology
1
Dermatology
1
Cancer
1
Virology
1
Public Health
1
Cardiovascular Diseases
1
Policies & Guidelines HIV & TB
1
Humanitarian Crisis
1
WASH
1
General Guidelines
1
Needs Assessment
1
Health Systems
1
Protection & Security
1
Neurology & Psychology
1
Malaria
1
Global Health
1
TB
1
Food Security & Nutrition
1
Toolboxes
Neurological Disorders
10
Substance Use Disorders & Addiction
9
Substance Use Disorders, Others
7
General Studies & Reports
7
Clean air
7
General Information & Methodology
7
General Information & Methodology
6
Global Overview
6
Global Burden of Disease
6
Africa
5
Meningitis Prevention & Control
5
Long COVID/ Post-COVID Syndrome
5
Alzheimer's Disease & Dementia
5
Dental Health
4
Stroke
4
Latin America
4
Vector control
4
General Information
4
Alcohol
3
Children & Adolescents
3
Children/Adolescents Mental Disorders
3
Epilepsy
3
IEC Substance Use Disorders
3
Climate & Health
3
Global Impact: Socio-economic, health services, TB & HIV
3
General
3
Planetary Health
3
Urban health
3
Mental Disorders
3
Overview, Studies & Reports
3
Asia
3
Vision Loss & Blindness
3
Depression
3
Neurological disorders, Others
3
Disability Rights & Convention
2
Drugs
2
HIV in Children and mental health
2
Introduction to Global Health
2
Training Manuals
2
mhGAP Guides
2
Curricula & Core Competencies
2
Mental Health Studies & Reports
2
Women's Mental Health
2
Sustainable Development Goals
2
Simulations
2
Country specific documents
2
Tips & Best Practice Examples
2
Health Promotion
2
Food environments
2
Guiding documents and principles
2
Zoonoses
2
Infectious Diseases
2
Non-communicable Diseases NCD
2
Health Impact & Climate Change
2
Chagas
2
Snakebite envenoming
2
General
2
Databases & Maps
2
others
2
General
2
Tobacco
2
Anxiety Disorders
2
Global Health Institutions and Stakeholders
2
Planetary Health
2
Global Health Financing
2
Best Practice Models
1
Violence & Child Trafficking
1
Local Action
1
General Reports
1
Surveillance
1
Laboratory Guidance
1
Training
1
Preparedness, Response & Risk Communication
1
Key Resources
1
Schizophrenia
1
Assessment & Response
1
HIV testing & disclosure
1
Children with disabilities
1
Concepts of Global Health
1
Orphans & vulnerable children
1
TB
1
Mental Health
1
Studies & Reports
1
Ebola
1
Maps
1
Training Supporting Material mhGAP
1
Training
1
HIV / AIDS
1
PPE Personel Protective Equipment
1
General
1
Clinical Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...d mitigating their consequences.more
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...s, age and sex, and recent trends in the use of drugs. The chapter also reviews the impact of the coronavirus disease (COVID-19) pandemic on drug use patterns and service provision. Other issues examined in the chapter are the health consequences of drug use, including the number of people in treatment for drug use disorders and the extent of drug injecting and of HIV and hepatitis C among people who inject drugs. The chapter concludes with a review of the extent to which strategies, policies and interventions are in place to respond to the drug use problem.more
Published OnlineJuly 14, 2021https://doi.org/10.1016/S2214-109X(21)00164-9. New Lancet research offers the first comprehensive analysis of the growing footprint of noncommunicable and injury-related neurological disorders to India’s overall disease burden.
Takeaways from 1990 to 2019 In terms ...of total disability adjusted life years:
• The share of noncommunicable neurological disorders doubled from 4% to 8.2%.
• Injury-related neurological disorders increased from 0.2% to 1.1%
• The contribution of communicable neurological disorders decreased from 4.1% to 1.1%
• Stroke, epilepsy, cerebral palsy, and headache disorders were among the largest contributors to DALYs.more
Almost 25% of deaths worldwide could be prevented if the actions in the compendium were fully implemented
This compendium provides a systematic compilation of published guidance from WHO and other UN organizations on health and environment. Guidance on policies and actions as well as awareness rais...ing and capacity building interventions is presented for all major areas of health and environment. Guidance referring to priority settings for action such as cities and other urban settlements, housing, workplaces and health care facilities is also listed.
For greater practical relevance, each guidance is classified according to principally involved sectors, level of implementation and instruments for implementation.
The compilation of guidance for each area of health and environment or priority setting for action is accompanied, as available, by information on main sources, exposure assessment and existing guideline values. Important tools and further resources are presented alongside.more
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...trengthening primary health care and health systems, increasing immunization coverage, improving global health security, fighting antimicrobial resistance and advocating for the rights of persons with disabilities. It will complement other global control strategies, such as those addressing sepsis, pneumonia, tuberculosis and HIV. Implementation will be a challenge for all countries across the world, but especially in resource-poor settings where the burden of meningitis is greatest. The targets for the visionary and strategic goals will be adapted to regional and local contexts.more
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les... 24 heures et un patient sur cinq peut rester handicapé à vie à la suite d’une infection. La plupart des cas et des décès dus à la méningite pourraient être évités par la vaccination mais les progrès obtenus pour la vaincre sont bien moins rapides que ceux réalisés contre d’autres maladies à prévention vaccinale.more
La meningitis es una enfermedad mortal y debilitante; golpea rápidamente, conlleva graves consecuencias sanitarias, económicas y sociales, y afecta a personas de todas las edades y en todos los países del mundo. La meningitis bacteriana puede provocar epidemias, ocasionar la muerte en 24 horas y ...dejar a una de cada cinco personas afectadas, con discapacidad permanente después de la infección. Muchos casos de meningitis y defunciones conexas son prevenibles mediante vacunación, pero los progresos para derrotar a la meningitis están rezagados respecto de otras enfermedades prevenibles mediante vacunación.more
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...y change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.more
Unhealthy diets and excess body weight are leading risk factors for death and disability in the WHO European Region. Addressing malnutrition in all its forms is essential to ensure health and well-being for all and, consequently, sustainable development. It requires coherent and innovative actions c...overing the entire food system and across other sectors to ensure access to a diversified, balanced and healthy diet for all.more
Die WHO hat mit Hilfe der Delphi-Methode eine klinische Falldefinition für das Post-COVID-19-Syndrom entwickelt, die 12 Domänen umfasst und in allen Bereichen verwendet werden kann. Diese erste Version wurde von Patienten, Forschern und anderen Personen aus allen WHO-Regionen entwickelt, wobei dav...on ausgegangen wird, dass sich die Definition ändern kann, wenn sich neue Erkenntnisse ergeben und sich unser Verständnis der Folgen von COVID-19 weiterentwickelt.
Die Post-COVID-19-Erkrankung tritt bei Personen mit einer wahrscheinlichen oder bestätigten SARS-CoV-2-Infektion in der Anamnese auf, in der Regel drei Monate nach dem Auftreten von COVID-19 mit Symptomen, die mindestens zwei Monate anhalten und nicht durch eine andere Diagnose erklärt werden können. Zu den häufigen Symptomen gehören Müdigkeit, Kurzatmigkeit, kognitive Störungen, aber auch andere Symptome, die sich im Allgemeinen auf das tägliche Leben auswirken. Die Symptome können nach der anfänglichen Genesung von einer akuten COVID-19-Episode neu auftreten oder nach der ersten Erkrankung fortbestehen. Die Symptome können auch schwanken oder im Laufe der Zeit wieder auftreten.more
L'OMS a développé une définition de cas clinique de l'état post COVID-19 par la méthodologie Delphi qui comprend 12 domaines, disponible pour une utilisation dans tous les contextes. Cette première version a été élaborée par des patients, des chercheurs et d'autres personnes, représentant... toutes les Régions de l'OMS, étant entendu que la définition peut changer à mesure que de nouvelles preuves apparaissent et que notre compréhension des conséquences de la COVID-19 continue d'évoluer.
L'état post COVID-19 survient chez les personnes ayant des antécédents d'infection probable ou confirmée par le CoV-2 du SRAS, généralement 3 mois après l'apparition de symptômes qui durent au moins 2 mois et ne peuvent être expliqués par un autre diagnostic. Les symptômes courants comprennent la fatigue, l'essoufflement, le dysfonctionnement cognitif mais aussi d'autres et ont généralement un impact sur le fonctionnement quotidien. Les symptômes peuvent être d'apparition récente après le rétablissement initial d'un épisode aigu de COVID-19 ou persister depuis la maladie initiale. Les symptômes peuvent également fluctuer ou rechuter au fil du temps.more
La OMS ha elaborado una definición de caso clínico de la afección posterior a la COVID-19 mediante la metodología Delphi que incluye 12 dominios, disponible para su uso en todos los entornos. Esta primera versión fue elaborada por pacientes, investigadores y otras personas, en representación d...e todas las regiones de la OMS, en el entendimiento de que la definición puede cambiar a medida que surjan nuevas pruebas y siga evolucionando nuestra comprensión de las consecuencias de la COVID-19.
La afección posterior a la COVID-19 se produce en personas con antecedentes de infección probable o confirmada por el CoV-2 del SRAS, normalmente a los 3 meses de la aparición de la COVID-19 con síntomas y que duran al menos 2 meses y no pueden explicarse por un diagnóstico alternativo. Los síntomas más comunes son la fatiga, la dificultad respiratoria y la disfunción cognitiva, pero también otros, y generalmente tienen un impacto en el funcionamiento diario. Los síntomas pueden ser de nueva aparición tras la recuperación inicial de un episodio agudo de COVID-19 o persistir desde la enfermedad inicial. Los síntomas también pueden fluctuar o recaer con el tiempo.more
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan...d the local manufacture of vaccines, diagnostics, and therapeutics. Presently, less than one percent of vaccines administered on the continent are manufactured locally. This places a great burden on the health systems of African countries and reduces their ability to respond to pandemics and other health crises.more
Mortality statistics are fundamental to public health decision making. Mortality varies by time and location, and its measurement is affected by well known biases that have been exacerbated during the COVID-19 pandemic. This paper aims to estimate excess mortality from ...the COVID-19 pandemic in 191 countries and territories, and 252 subnational units for selected countries, from Jan 1, 2020, to Dec 31, 2021.
The Lancet. 10 March 2022. doi: 10.1016/S0140-6736(21)02796-3.more
Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339
The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and vector-borne infectious diseases, and... respiratory illness from smog, ozone, allergenic pollen, and wildfires. Recent reports from the Intergovernmental Panel on Climate Change stress the urgent need for action to mitigate climate change, underscoring the need for more scientific assessment of the benefits of climate action for health and wellbeing.more
During the first year of the Covid-19 pandemic, the world’s economy slowed. Yet, the global annual average particulate pollution (PM2.5) was largely unchanged from 2019 levels. At the same time, growing evidence shows air pollution—even when experienced at very low levels—hurts human health. T...his recently led the World Health Organization (WHO) to revise its guideline for what it considers a safe level of exposure of particulate pollution, bringing most of the world—97.3 percent of the global population—into the unsafe zone. The AQLI finds that particulate air pollution takes 2.2 years off global average life expectancy, or a combined 17 billion life-years, relative to a world that met the WHO guideline. This impact on life expectancy is comparable to that of smoking, more than three times that of alcohol use and unsafe water, six times that of HIV/AIDS, and 89 times that of conflict and terrorism.more
La salud es un estado de perfecto (completo) bienestar físico, mental y social, y no sólo la ausencia de enfermedad. El Estado Peruano reconoce a la salud como derecho fundamental, estableciendo que toda persona tiene derecho a la protección de su salud, la del medio familiar y la de la comunidad..., así como el deber de contribuir a su promoción y su defensa. La salud es derecho en lo cual es condición indispensable del desarrollo humano y medio fundamental para alcanzar el bienestar individual y colectivo y que la protección de la salud es de interés público, por tanto, es responsabilidad del Estado regularla, vigilarla y promoverlamore
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...l public.
Les notes de synthèse s’adressent aux responsables nationaux de la santé publique et aux administrateurs des programmes de vaccination, mais elles peuvent également présenter un intérêt pour les organismes internationaux de financement, les groupes consultatifs sur la vaccination, les fabricants de vaccins, les professionnels de la santé, les chercheurs, les médias scientifiques et le grand public.more